Noesis Capital Mangement Corp Bio N Tech Se Transaction History
Noesis Capital Mangement Corp
- $451 Billion
- Q2 2024
A detailed history of Noesis Capital Mangement Corp transactions in Bio N Tech Se stock. As of the latest transaction made, Noesis Capital Mangement Corp holds 2,500 shares of BNTX stock, worth $306,700. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,500
Previous 2,500
-0.0%
Holding current value
$306,700
Previous $231 Million
12.89%
% of portfolio
0.04%
Previous 0.05%
Shares
1 transactions
Others Institutions Holding BNTX
# of Institutions
328Shares Held
40.6MCall Options Held
845KPut Options Held
1.23M-
Baillie Gifford & CO8.28MShares$1.02 Billion0.53% of portfolio
-
Primecap Management CO Pasadena, CA4.79MShares$588 Million0.28% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.38MShares$537 Million1.49% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.93MShares$359 Million1.34% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$233 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $29.8B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...